Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CANCER GENETICS, INC.

(CGIX)
SummaryChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cancer Genetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020

03/31/2021 | 06:01am EST

Cancer Genetics, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 5.751 million compared to USD 7.305 million a year ago. Operating loss was USD 8.183 million compared to USD 5.703 million a year ago. Net loss was USD 8.001 million compared to USD 6.708 million a year ago. Basic loss per share was USD 3.16 compared to USD 3.48 a year ago. Basic loss per share from continuing operations was USD 3.18 compared to USD 3.57 a year ago.


ę S&P Capital IQ 2021
All news about CANCER GENETICS, INC.
04/06CANCER GENETICS : Vyant Bio Presentation – April 2021
PU
03/31Cancer Genetics and StemoniX Announce Merger Closing
GL
03/31CANCER GENETICS : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
03/31Cancer Genetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
CI
03/31Cancer Genetics, Inc. has Changed its Ticker to VYNT from CGIX
CI
03/30Cancer Genetics, Inc. has Changed its Name to Vyant Bio, Inc
CI
03/30CANCER GENETICS, INC.(NASDAQCM : CGIX) dropped from NASDAQ Composite Index
CI
03/30StemoniX Inc. completed the acquisition of Cancer Genetics, Inc. from a group of shareh..
CI
03/25CANCER GENETICS : Secures Shareholder Nod for Proposed StemoniX Merger
MT
03/25CANCER GENETICS, INC : Submission of Matters to a Vote of Security Holders, Other Events (..
AQ
More news
Chart CANCER GENETICS, INC.
Duration : Period :
Cancer Genetics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart